Pantothenate - kinase associated neurodegeneration. - <a href="../public/authorSummary-Parmar, Alpana.do">Alpana Parmar</a>, <a href="../public/authorSummary-Khare, Shruti.do">Shruti Khare</a>, <a href="../public/authorSummary-Srivastav, Vipul.do">Vipul Srivastav</a>

Abstract	Neurodegeneration with brain iron accumulation is a group of disorders, the commonest of which is PKAN (Pantothenate kinase associated neurodegeneration). We present here, a case of 18 year old boy with progressive dementia, pyramidal and extrapyramidal involvement, dysarthria, seizures and myoclonus. The patient was diagnosed as PKAN (formerly Hallervorden Spatz disease) after "eye of tiger" appearance on neuro-imaging.
Authors	Alpana Parmar, Shruti Khare, Vipul Srivastav
Journal	The Journal of the Association of Physicians of India (J Assoc Physicians India) Vol. 60 Pg. 74-6 (Apr 2012) ISSN: 0004-5772 [Print] India
PMID	23029753 (Publication Type: Case Reports, Journal Article)
Chemical References	Cholinergic Antagonists Muscle Relaxants, Central
Topics	Adolescent Cholinergic Antagonists (therapeutic use) Humans Magnetic Resonance Imaging Male Muscle Relaxants, Central (therapeutic use) Pantothenate Kinase-Associated Neurodegeneration (diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!